Ocular Therapeutix (OCUL) Tops Q4 EPS by 1c

Ocular Therapeutix (NASDAQ: OCUL) reported Q4 EPS of ($0.24), $0.01 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $14.1 million versus the consensus estimate of $13.42 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• UBS says bull market has further to run
• PennyMac Mortgage Investment Trust (PMT) PT Lowered to $10 by UBS on Lower MSR Earnings
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04